Koers Teva Pharmaceutical Industries Limited OTC Markets
Aandelen
TEVJF
IL0006290147
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,92 USD | -10,71% | -10,71% | +73,09% |
Omzet 2024 * | 15,95 mld. 14,7 mld. | Omzet 2025 * | 16,54 mld. 15,25 mld. | Marktkapitalisatie | 19,17 mld. 17,68 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 820 mln. 756 mln. | Nettowinst (verlies) 2025 * | 1,39 mld. 1,28 mld. | EV/omzet 2024 * | 2,14 x |
Nettoschuld 2024 * | 14,93 mld. 13,76 mld. | Nettoschuld 2025 * | 12,41 mld. 11,44 mld. | EV/omzet 2025 * | 1,91 x |
K/w-verhouding 2024 * |
17,9
x | K/w-verhouding 2025 * |
12,3
x | Werknemers | 35.737 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,44% |
Recentste transcriptie over Teva Pharmaceutical Industries Limited
1 dag | -10,71% | ||
1 week | -10,71% | ||
1 maand | +26,98% | ||
3 maanden | +20,61% | ||
6 maanden | +58,72% | ||
Lopend jaar | +73,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01-01-23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22-12-19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01-09-15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09-06-20 |
Sol Barer
CHM | Chairman | 76 | 01-01-15 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
29-05-24 | 14,92 | -10,71% | 300 |
24-05-24 | 16,71 | +3,00% | 217 |
uitgestelde koers OTC Markets, 29 mei 2024 om 15:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |
- Beurs
- Aandelen
- Koers TEVA
- Koers TEVJF